$69.54
00.00%
Pre-Market: 4:48 PM EDT
Comments
Loading...
Edwards Lifesciences (NYSE:EW) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Edwards Lifesciences (EW)?
The most recent guidance for Edwards Lifesciences (EW) was reported on October 24, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $0.53 to $0.57, compared to the estimated EPS of $0.62. Additionally, Edwards Lifesciences forecasted revenue between $1.33B and $1.39B for the quarter.
Browse guidance and forecast on all stocks.